Search for: "Grant v. Bristol-Myers Squibb"
Results 81 - 100
of 140
Sorted by Relevance
|
Sort by Date
24 May 2012, 4:23 am
Bristol-Myers Squibb Co., 2011 WL 2784101, at *3 (D.N.J. 2011), the Court did not hold that the warning label was enough to give notice. [read post]
2 Jun 2011, 12:46 pm
Squibb & Sons, Inc. v. [read post]
10 Jun 2009, 10:00 pm
Bristol-Myers Squibb, 1998 WL 812318, at 30 (M.D. [read post]
31 Oct 2008, 11:53 am
You can separately subscribe to the Pharma & Biotech edition of the IP Think Tank Global Week in Review by subscribing by email, or selecting ‘all posts’ or ‘Pharma, Biotech & Chem’ for the RSS option at the Subscribe page: [duncanbucknell.com] Highlights this week included: Oxytrol (Oxybutynin) - US: Watson files patent infringement lawsuit against Barr over application to market generic Oxytrol; Barr challenges Oxytrol patent… [read post]
12 May 2022, 6:45 am
Paul Reed Smith Guitars, LP, 423 F.3d 539 (6th Cir. 2005). [3] Bristol-Myers Squibb Co. v. [read post]
4 Feb 2013, 2:07 pm
Bristol—Myers Squibb Co., No. 07-1098 (FLW), 2013 U.S. [read post]
4 Nov 2010, 6:14 am
”); Bristol-Myers Squibb Co. v. [read post]
18 Mar 2011, 10:04 am
Bristol-Myers Squibb, 97 F. [read post]
7 Nov 2022, 9:01 pm
Supreme Court, which granted certiorari. [read post]
3 Mar 2010, 5:05 am
‘The solution lies in resources’ says FDA Commissioner Hamburg (FDA Law Blog) Products Actoplus MET (Pioglitazone) – US: Takeda files patent infringement suit against Aurobindo following Para IV certification as part of ANDA to manufacture generic Actoplus MET (Patent Docs) Advair diskus (Fluticasone, Salmeterol) – US: PTO denies PTE for Advair diskus patent; Office again clarifies that PTEs are not availabile for ‘synergistic combinations’ containing… [read post]
3 Mar 2010, 5:05 am
‘The solution lies in resources’ says FDA Commissioner Hamburg (FDA Law Blog) Products Actoplus MET (Pioglitazone) – US: Takeda files patent infringement suit against Aurobindo following Para IV certification as part of ANDA to manufacture generic Actoplus MET (Patent Docs) Advair diskus (Fluticasone, Salmeterol) – US: PTO denies PTE for Advair diskus patent; Office again clarifies that PTEs are not availabile for ‘synergistic combinations’ containing… [read post]
9 Dec 2009, 3:59 pm
(Patent Docs) (SmartBrief) (GenericsWeb) OxyContin (Oxycodone) – US: Ranbaxy admits infringement in OxyContin suit – District Court S D New York approves consent judgment between Ranbaxy and Purdue Pharma (Patent Docs) Reyataz (Atazanavir) – US: Complaint filed in Delaware: Infringement of US patent following a Paragraph IV challenge: Bristol-Myers Squibb Co. et al. v. [read post]
18 Feb 2020, 4:00 am
A patent defines a monopoly granted to an inventor in consideration of the disclosure of the invention to the public. [read post]
18 Jan 2017, 7:35 am
Bristol-Myers Squibb Co. v. [read post]
27 Jan 2017, 12:52 pm
The court also granted last Thursday in the much less colorful two-time relist Bristol-Myers Squibb Company v. [read post]
19 Apr 2022, 8:00 am
Apple Inc. v. [read post]
17 May 2021, 1:12 pm
“And Trimble is headquartered in California, connecting California to Trimble’s claims, which is a consideration the Court in Ford found relevant in distinguishing its earlier decision in Bristol-Myers. [read post]
17 Nov 2010, 1:48 am
(Patents Post Grant Blog) US: University inventions, Stanford vs Roche (IPEG) US: What ultimately matters in deciding the ‘gene patenting’ issue? [read post]
7 Nov 2014, 5:52 am
Ellis v. [read post]
21 Apr 2024, 2:35 pm
(quoting Bristol-Myers Squibb Co. v. [read post]
